Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biopharmaceutical benchmarks 2006.

Gary Walsh1

  • 1Industrial Biochemistry Programme, University of Limerick, Limerick, Ireland. gary.walsh@ul.ie

Nature Biotechnology
|July 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Truncation of a novel C-terminal domain of a β-glucanase improves its thermal stability and specific activity.

Biotechnology journal·2024
Same author

Recombinant production, characterization and industrial application testing of a novel acidic exo/endo-chitinase from Rasamsonia emersonii.

Extremophiles : life under extreme conditions·2023
Same author

Biopharmaceutical benchmarks 2022.

Nature biotechnology·2022
Same author

Production, characteristics and applications of microbial heparinases.

Biochimie·2022
Same author

Recombinant production and characterisation of two chitinases from Rasamsonia emersonii, and assessment of their potential industrial applicability.

Applied microbiology and biotechnology·2021
Same author

Purification and Characterization of a Novel β-Galactosidase From the Thermoacidophile Alicyclobacillus vulcanalis.

Applied biochemistry and biotechnology·2020
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

A retargeted recombinase for precise insertion of large DNA.

Nature biotechnology·2026
Same journal

Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles.

Nature biotechnology·2026
Same journal

Spatially resolved profiling of extracellular vesicles in tissues with Spatial-EV-seq.

Nature biotechnology·2026
See all related articles

Biopharmaceutical approvals have plateaued, but recent advancements suggest a positive future outlook for drug development and patient access. Key milestones indicate potential for future therapeutic innovations.

Area of Science:

  • Pharmacology and Drug Development
  • Biotechnology
  • Regulatory Science

Background:

  • The biopharmaceutical industry is crucial for developing novel therapeutics.
  • Monitoring approval rates provides insights into industry innovation and healthcare progress.
  • Recent trends indicated a potential slowdown in new drug approvals.

Purpose of the Study:

  • To analyze the recent trends in biopharmaceutical approval rates.
  • To identify key milestones that may influence future drug development.
  • To provide an outlook on the future of biopharmaceutical innovation.

Main Methods:

  • Analysis of publicly available data on biopharmaceutical approvals.
  • Review of regulatory agency reports and industry publications.

Related Experiment Videos

  • Identification and categorization of significant developmental milestones.

    • Main Results:

    • Biopharmaceutical approval rates have stabilized in recent periods.
    • Several key milestones in areas like gene therapy and personalized medicine have been achieved.
    • These milestones indicate a robust pipeline and potential for future breakthroughs.

    Conclusions:

    • While overall approval rates have leveled, the scientific progress and specific achievements signal a promising future for biopharmaceuticals.
    • Continued innovation in specialized therapeutic areas is expected.
    • These developments are likely to enhance treatment options for various diseases.